Bicudo, Edison;
Brass, Irina;
Carmichael, Penelope;
(2022)
Point-of-care manufacture of advanced therapies: readiness measures for hospitals, companies, and regulatory agencies.
Future Targeted Healthcare Manufacturing Hub, UCL: London, UK.
Preview |
Text
POCM of ATMPs: Readiness Brief.pdf - Other Download (2MB) | Preview |
Abstract
Advanced Therapy Medicinal Products (ATMPs), such as cell and gene therapies, are promising for treating rare diseases, as well as some more prevalent conditions such as severe burns or diabetes. In some cases, it is necessary to adopt models where ATMPs are produced in clinical settings and immediately delivered to patients (point -of-care manufacture). This could enlarge the range of innovative therapies made available in the NHS, but also brings about considerable challenges.
| Type: | Report |
|---|---|
| Title: | Point-of-care manufacture of advanced therapies: readiness measures for hospitals, companies, and regulatory agencies |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://www.ucl.ac.uk/steapp/sites/steapp/files/po... |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > STEaPP UCL > Provost and Vice Provost Offices > UCL BEAMS UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10152569 |
Archive Staff Only
 |
View Item |
